Latest CNCE reports update at 2022-11-07: 2022-Q32022-Q22022-Q1
Concert Pharmaceuticals logo
Concert Pharmaceuticals CNCE
$ 8.37 0.0%

Concert Pharmaceuticals Operating Income 2011-2024 | CNCE

Annual Operating Income Concert Pharmaceuticals

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-77.5 M -72.6 M -79 M -55.6 M 92.6 M -51.2 M 24.8 M -30.6 M -4.41 M -18.6 M -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
92.6 M -79 M -27.2 M

Quarterly Operating Income Concert Pharmaceuticals

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- -29.6 M - -36 M - -26.8 M 6.22 M -24 M -21.5 M -19.4 M -13.1 M -18.7 M -21 M -18.2 M -19.4 M -20.4 M -20.1 M -17.3 M -14.4 M -3.81 M -12.7 M 132 M -13 M -13.5 M -12.2 M -11.5 M -13.6 M -14 M 663 K -8.69 M 41.7 M -8.87 M -8.74 M -7.61 M -7.73 M -6.52 M -5.58 M -7.12 M 9.42 M -1.13 M - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
132 M -36 M -7.73 M